Curated from 2,322 episode summaries
Peptides went from a gray-market bodybuilding secret to a mainstream conversation almost overnight, and podcasts are where most people are actually learning about them, for better and worse. We combed through our full library of episode summaries and pulled the conversations that go past the Instagram hype and into mechanism, regulation, and risk.
Below are seven episodes, ranging from urologists and internal medicine doctors to a compounding-pharmacy founder and a supplement-industry insider, that cover what peptides do, why the FDA banned then reconsidered them, and which compounds are worth a second look versus which ones are mostly gray-market gambling.
Peptide Expert: What Do Peptides Actually Do? (EXPLAINED) - Dr Alex Tatem
If you only listen to one episode on this list, make it this one. Dr Alex Tatem, a urologist who runs a popular peptide-education channel, ties the 2023 peptide ban directly to a 2013 Supreme Court ruling that stripped patent protection from natural compounds, arguing pharma had no incentive to fight for peptides once they couldn't own them. He also reports that the FDA is considering returning seven peptides, including BPC-157, to legal status. This is the clearest primer on the regulatory backstory and belongs first for anyone confused about why peptides disappeared and might be coming back.
Read the full episode notesPeptides: The Science, Uses & Safety | Dr. Abud Bakri
An internal medicine physician gives Huberman a genuine masterclass, sorting peptides into those with known receptors, like the GLP-1 drugs, versus those without, like BPC-157, and walking through the evidence for each. The reveal that every peptide's raw material comes from China, with no such thing as an American-made version, reframes the entire supply-chain conversation, as does his estimate that $5-10 billion moved through the gray market in 2025 alone. Best for listeners who want the science broken down compound by compound without the sales pitch.
Read the full episode notesJoe Rogan Experience #2079 - Brigham Buhler
Ways2Well founder Brigham Buhler makes the case that peptides weren't banned for safety but reclassified as 'dangerous' to scare doctors into avoiding them while pharma quietly moves to patent over 200 of the same compounds. His claim that a former DOJ prosecutor watched pharmacy benefit managers push for federal indictments against compounding pharmacies is a jaw-dropper. Good for listeners who want the industry-conspiracy angle laid out by someone who built a business around cash-pay preventative medicine.
Read the full episode notesJoe Rogan Experience #2469 - Brigham Buhler
Buhler returns to Rogan with an update: the Trump administration is reportedly working to reclassify the 19 peptides banned under Biden, and he says he's the most optimistic he's been on the issue. The episode's standout stat is that four out of five peptides and GLP-1s currently move through the gray or black market with zero clinician oversight, which reframes the 'ban vs. legalize' debate as a safety issue either way. Listen for the regulatory-momentum update and his pitch for MUSE stem cells as the next frontier.
Read the full episode notesHow to Optimize Your Hormones for Health & Vitality | Dr. Kyle Gillett
This is less a peptide episode than a full hormone-health framework with peptides woven throughout, which is exactly why it's useful. Dr. Kyle Gillett covers testosterone, DHT, estrogen, and prolactin before getting into peptide risk and benefit, and the detail that starting TRT drastically raises sleep apnea risk even in men with normal baseline testosterone is a genuine surprise. Best for anyone who wants peptides in the context of the broader hormone picture rather than in isolation.
Read the full episode notesJoe Rogan Experience #2421 - Derek, More Plates More Dates
Derek, founder of Gorilla Mind and Marek Health, brings the supplement-and-PED insider view, covering everything from nootropic formulation to steroids, TRT, and tanning peptides inside a much wider conversation about physique-enhancing drugs. His breakdown of how the 1990s Women's Health Initiative produced a misleading 26% breast-cancer headline using horse-urine estrogen is a detour worth staying for. Good for listeners who want peptides positioned alongside the rest of the performance-enhancement toolkit rather than treated as a standalone topic.
Read the full episode notesJoe Rogan Experience #2512 - Joey Diaz
Not a peptide deep dive, but a real-world data point: Joey Diaz shows up fresh off knee replacement surgery and talks with Rogan about using peptides, nootropics, and supplements during recovery, in between stories about his Boulder crime years and Cuba's collapse. It's here for listeners who want to hear peptides discussed the way most people actually encounter them, casually, mid-recovery, alongside everything else in life, rather than in a clinical setting.
Read the full episode notesThat's seven ways into the peptide conversation, from the regulatory weeds to the gray-market reality to a guy just trying to heal his knee. Browse the full episode summaries on Episode Notes for more on hormone health, longevity medicine, and everything else these guests get into.